Trulieve Cannabis Corp. (NYSE:TRLV) Short Interest Update

Trulieve Cannabis Corp. (NYSE:TRLV) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 809,950 shares, a growth of 174.1% from the June 15th total of 295,465 shares. Based on an average daily trading volume, of 2,214,683 shares, the short-interest ratio is presently 0.4 days. Approximately 0.4% of the company’s shares are short sold.

Trulieve Cannabis Trading Up 3.9%

Shares of TRLV opened at $8.96 on Tuesday. Trulieve Cannabis has a 52-week low of $4.00 and a 52-week high of $13.28.

Wall Street Analysts Forecast Growth

Several brokerages have commented on TRLV. Zacks Research upgraded shares of Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings began coverage on Trulieve Cannabis in a research report on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. Finally, Wall Street Zen cut Trulieve Cannabis from a “strong-buy” rating to a “buy” rating in a research note on Sunday. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Trulieve Cannabis has an average rating of “Reduce”.

Insider Transactions at Trulieve Cannabis

In other Trulieve Cannabis news, CEO Kim A. Rivers sold 400,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $8.17, for a total value of $3,268,000.00. Following the transaction, the chief executive officer directly owned 1,913,724 shares of the company’s stock, valued at approximately $15,635,125.08. This trade represents a 17.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,699,007 shares of company stock valued at $14,661,355 over the last quarter. 3.79% of the stock is currently owned by company insiders.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.